Gilead Sciences Photos

Gilead Alberta ULC

+ Add Photo

Gilead Sciences Reviews

2.9
Rating Trends
Recommend to a friend
Approve of CEO
Gilead Sciences Chairman & CEO John C. Martin
John C. Martin
121 Ratings
  • Helpful (2)

    Review

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Gilead Sciences

    Recommends
    Positive Outlook
    Approves of CEO
    Recommends
    Positive Outlook
    Approves of CEO

    Pros

    Good energy and mission - feels good to work for a company that has a strong mission.

    Cons

    Too lean; not enough people to do all the work.


Gilead Sciences Interviews

Interview Experience

Interview Experience

62%
25%
12%

Getting an Interview

Getting an Interview

40%
29%
13%

Interview Difficulty

3.1
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Project Manager Interview

    Anonymous Interview Candidate
    Accepted Offer
    Positive Experience
    Difficult Interview

    Interview

    Panel Interviews, Phone Interviews, Screening process, technical details, project related questions, detailed discussions with all levels of management, team members, cross functional team members as well, critical thinking, decision making

    Interview Questions

Gilead Sciences Awards & Accolades

Something missing? Add an award
100 Fastest Growing Companies, Fortune, 2009
America's Top Companies, Forbes, 2009
Show More

Additional Info

Unlock Profile
Website www.gilead.com
Headquarters Foster City, CA
Size 5000+ Employees
Founded 1987
Type Company - Public (GILD)
Industry Biotech & Pharmaceuticals
Revenue $10+ billion (USD) per year

Gilead Sciences has biotech balms for infectious diseases, including hepatitis, HIV, and infections related to AIDS. The company's HIV franchise includes Truvada, a combination of two of its other drugs, Viread and Emtriva. It co-promotes another HIV treatment, called Atripla, in the US and Europe with Bristol-Myers Squibb. Other products on the market include AmBisome, used to treat systemic fungal infections such as those that accompany AIDS; Vistide, for AIDS-related eye infections; and hepatitis B antiviral Hepsera. Beyond HIV/AIDS, Gilead also markets Letairis, a... More

Work at Gilead Sciences? Share Your Experiences

Gilead Sciences

 
Click to Rate
or